Geoff Shapiro, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Geoff Shapiro, Dana-Farber Cancer Institute

Caption

Geoffrey Shapiro, M.D., and colleagues at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.

Credit

Sam Ogden

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.